Xiangqing Xu

Jiangsu Nhwa Pharmaceutical Co Ltd And Jiangsu Key Laboratory Of Central Nervous System Drug Research And Development
Xuzhou, 221116, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Kappa opioid receptor antagonism in neuropsychiatry: from molecular mechanisms to clinical prospects.

Kappa opioid receptor antagonism in neuropsychiatry: from molecular mechanisms to clinical prospects.

Journal: European archives of psychiatry and clinical neuroscience

Published: November 04, 2025

Neuropsychiatric drug development in China: Current status and emerging trends.

Neuropsychiatric drug development in China: Current status and emerging trends.

Journal: Molecular psychiatry

Published: February 18, 2025

S-ketamine alleviates morphine-induced hyperalgesia via decreasing the gut Enterobacteriaceae levels: Comparison with R-ketamine.

S-ketamine alleviates morphine-induced hyperalgesia via decreasing the gut Enterobacteriaceae levels: Comparison with R-ketamine.

Journal: Neuroscience

Published: October 30, 2024

Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H3 Agents: Synthesis and Biological Evaluation.

Amphetamine Derivatives as Potent Central Nervous System Multitarget SERT/NET/H3 Agents: Synthesis and Biological Evaluation.

Journal: Molecules (Basel, Switzerland)

Published: October 15, 2024

Design, synthesis and biological evaluation of arylpropylamine derivatives as potential multi-target antidepressants.

Design, synthesis and biological evaluation of arylpropylamine derivatives as potential multi-target antidepressants.

Journal: Bioorganic & medicinal chemistry

Published: August 26, 2024

The Impact of Comprehensive Nursing and Warming Measures on Emergence Agitation and Maternal-Neonatal Safety in Women Undergoing General Anesthesia for Cesarean Section.

The Impact of Comprehensive Nursing and Warming Measures on Emergence Agitation and Maternal-Neonatal Safety in Women Undergoing General Anesthesia for Cesarean Section.

Journal: Alternative therapies in health and medicine

Published: May 03, 2024

Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia.

Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia.

Journal: Frontiers in pharmacology

Published: September 21, 2023

A novel dual serotonin transporter and M-channel inhibitor D01 for antidepression and cognitive improvement.

A novel dual serotonin transporter and M-channel inhibitor D01 for antidepression and cognitive improvement.

Journal: Acta pharmaceutica Sinica. B

Published: August 02, 2023

The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamine.

The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamine.

Journal: Brain, behavior, and immunity

Published: June 20, 2023

Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine.

Myelin-associated oligodendrocytic basic protein-dependent myelin repair confers the long-lasting antidepressant effect of ketamine.

Journal: Molecular psychiatry

Published: May 24, 2023

Carbazole and tetrahydro-carboline derivatives as dopamine D3 receptor antagonists with the multiple antipsychotic-like properties.

Carbazole and tetrahydro-carboline derivatives as dopamine D3 receptor antagonists with the multiple antipsychotic-like properties.

Journal: Acta pharmaceutica Sinica. B

Published: March 17, 2023

Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota.

Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota.

Journal: Neuropharmacology

Published: September 08, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026